digital currency the future, People searches

Just when everyone was still sick, A-shares ushered in good news. Shanghai issued the "Shanghai Action Plan to Support the Merger and Reorganization of Listed Companies (2025-2027)". Is this to retain injured retail investors? Next, let's discuss it in detail.From the above four points of view, I think I will stay. As long as the upward trend of A shares is still there, I will not leave easily, so I can grasp the rhythm of high selling and low sucking.First, Tuesday's market rally was really disgusting to everyone, but the good thing was to cover the gap of the day's upward gap and rule out the hidden danger of covering the gap in the market outlook.

Third, cultivate about 10 internationally competitive listed companies in the field;Fourth, other fields also involve industrial chains such as electronic information generation, a new generation of intelligent networked vehicles and new energy vehicles, and also mention accelerating the merger of securities companies.Fourth, other fields also involve industrial chains such as electronic information generation, a new generation of intelligent networked vehicles and new energy vehicles, and also mention accelerating the merger of securities companies.

From the above four points of view, I think I will stay. As long as the upward trend of A shares is still there, I will not leave easily, so I can grasp the rhythm of high selling and low sucking.Shanghai's announcement of the action plan for mergers and acquisitions of listed companies is indeed a heavy news. However, can this still retain the retail investors who were hurt by the market on Tuesday? On Tuesday, A shares opened higher and fell back, which triggered a crisis of confidence in the market to some extent. So, shall we go or stay? Let me express my personal views.Second, the key areas mainly involve integrated circuits, biomedicine, new materials and other industries. Make good use of the 10 billion yuan integrated circuit design industry M&A fund and set up a 10 billion yuan biomedical industry M&A fund;